Blood Money

In a desperate attempt to stave off bankruptcy Senseonics entered into a new financing agreement yesterday. Per a press release;

“Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that it has entered into a new senior secured Term Loan Agreement with certain funds managed by Highbridge Capital Management, LLC (“Highbridge”), an existing stakeholder. Pursuant to the Term Loan Agreement, the Company will draw down $15.0 million from the new First Lien Secured Term Loan with . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.